Hubei Guangji Pharmaceutical Co., Ltd. (000952.SZ)
CNY 6.24
(-0.79%)
CNY 6.24
(-0.79%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 3.02 Billion CNY | 22.7% |
| 2022 | 2.46 Billion CNY | 20.51% |
| 2021 | 2.04 Billion CNY | 3.51% |
| 2020 | 1.97 Billion CNY | 12.05% |
| 2019 | 1.76 Billion CNY | 4.32% |
| 2018 | 1.69 Billion CNY | 3.13% |
| 2017 | 1.64 Billion CNY | 0.49% |
| 2016 | 1.63 Billion CNY | 0.81% |
| 2015 | 1.62 Billion CNY | 2.42% |
| 2014 | 1.58 Billion CNY | 1.97% |
| 2013 | 1.55 Billion CNY | -0.27% |
| 2012 | 1.55 Billion CNY | 3.27% |
| 2011 | 1.5 Billion CNY | 8.83% |
| 2010 | 1.38 Billion CNY | 6.18% |
| 2009 | 1.3 Billion CNY | 8.02% |
| 2008 | 1.2 Billion CNY | 20.86% |
| 2007 | 998.75 Million CNY | 27.23% |
| 2006 | 785.02 Million CNY | -11.04% |
| 2005 | 882.44 Million CNY | -3.24% |
| 2004 | 911.95 Million CNY | 5.19% |
| 2003 | 866.93 Million CNY | 5.74% |
| 2002 | 819.9 Million CNY | 7.62% |
| 2001 | 761.83 Million CNY | 12.66% |
| 2000 | 676.21 Million CNY | 4.23% |
| 1999 | 648.78 Million CNY | 71.29% |
| 1998 | 378.75 Million CNY | 13.72% |
| 1997 | 333.04 Million CNY | 36.0% |
| 1996 | 244.89 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 3.01 Billion CNY | -0.54% |
| 2024 Q2 | 3.11 Billion CNY | 3.49% |
| 2024 Q3 | 3.1 Billion CNY | -0.3% |
| 2023 Q2 | 3.24 Billion CNY | 31.95% |
| 2023 Q3 | 3.17 Billion CNY | -2.07% |
| 2023 Q1 | 2.45 Billion CNY | -0.38% |
| 2023 FY | 3.02 Billion CNY | 22.7% |
| 2023 Q4 | 3.02 Billion CNY | -4.67% |
| 2022 FY | 2.46 Billion CNY | 20.51% |
| 2022 Q4 | 2.46 Billion CNY | 5.01% |
| 2022 Q3 | 2.35 Billion CNY | 6.3% |
| 2022 Q2 | 2.21 Billion CNY | -4.52% |
| 2022 Q1 | 2.31 Billion CNY | 13.06% |
| 2021 Q3 | 2.02 Billion CNY | -6.5% |
| 2021 Q4 | 2.04 Billion CNY | 0.97% |
| 2021 Q1 | 1.95 Billion CNY | -1.45% |
| 2021 Q2 | 2.17 Billion CNY | 11.25% |
| 2021 FY | 2.04 Billion CNY | 3.51% |
| 2020 Q2 | 2.06 Billion CNY | -1.14% |
| 2020 Q1 | 2.08 Billion CNY | 18.02% |
| 2020 Q3 | 2.05 Billion CNY | -0.54% |
| 2020 Q4 | 1.97 Billion CNY | -3.44% |
| 2020 FY | 1.97 Billion CNY | 12.05% |
| 2019 Q2 | 1.82 Billion CNY | 1.67% |
| 2019 Q1 | 1.79 Billion CNY | 6.02% |
| 2019 FY | 1.76 Billion CNY | 4.32% |
| 2019 Q3 | 1.77 Billion CNY | -2.81% |
| 2019 Q4 | 1.76 Billion CNY | -0.43% |
| 2018 Q1 | 1.71 Billion CNY | 4.21% |
| 2018 FY | 1.69 Billion CNY | 3.13% |
| 2018 Q4 | 1.69 Billion CNY | 4.95% |
| 2018 Q3 | 1.61 Billion CNY | -4.11% |
| 2018 Q2 | 1.68 Billion CNY | -1.66% |
| 2017 Q2 | 1.61 Billion CNY | 2.05% |
| 2017 FY | 1.64 Billion CNY | 0.49% |
| 2017 Q1 | 1.58 Billion CNY | -3.21% |
| 2017 Q3 | 1.69 Billion CNY | 5.25% |
| 2017 Q4 | 1.64 Billion CNY | -3.34% |
| 2016 Q2 | 1.65 Billion CNY | 0.55% |
| 2016 FY | 1.63 Billion CNY | 0.81% |
| 2016 Q4 | 1.63 Billion CNY | -0.13% |
| 2016 Q3 | 1.63 Billion CNY | -1.44% |
| 2016 Q1 | 1.65 Billion CNY | 1.86% |
| 2015 Q2 | 1.7 Billion CNY | 13.53% |
| 2015 FY | 1.62 Billion CNY | 2.42% |
| 2015 Q4 | 1.62 Billion CNY | 2.1% |
| 2015 Q3 | 1.58 Billion CNY | -7.13% |
| 2015 Q1 | 1.5 Billion CNY | -4.86% |
| 2014 Q2 | 1.58 Billion CNY | 1.99% |
| 2014 Q4 | 1.58 Billion CNY | 2.35% |
| 2014 FY | 1.58 Billion CNY | 1.97% |
| 2014 Q1 | 1.55 Billion CNY | 0.38% |
| 2014 Q3 | 1.54 Billion CNY | -2.68% |
| 2013 FY | 1.55 Billion CNY | -0.27% |
| 2013 Q3 | 1.59 Billion CNY | 2.12% |
| 2013 Q2 | 1.56 Billion CNY | -2.48% |
| 2013 Q1 | 1.6 Billion CNY | 2.97% |
| 2013 Q4 | 1.55 Billion CNY | -2.74% |
| 2012 Q4 | 1.55 Billion CNY | 0.99% |
| 2012 Q3 | 1.54 Billion CNY | 3.17% |
| 2012 Q1 | 1.53 Billion CNY | 2.2% |
| 2012 FY | 1.55 Billion CNY | 3.27% |
| 2012 Q2 | 1.49 Billion CNY | -3.02% |
| 2011 FY | 1.5 Billion CNY | 8.83% |
| 2011 Q2 | 1.46 Billion CNY | 0.92% |
| 2011 Q4 | 1.5 Billion CNY | 0.61% |
| 2011 Q1 | 1.44 Billion CNY | 4.69% |
| 2011 Q3 | 1.49 Billion CNY | 2.38% |
| 2010 Q2 | 1.4 Billion CNY | 9.3% |
| 2010 FY | 1.38 Billion CNY | 6.18% |
| 2010 Q3 | 1.4 Billion CNY | -0.33% |
| 2010 Q1 | 1.28 Billion CNY | -1.15% |
| 2010 Q4 | 1.38 Billion CNY | -1.4% |
| 2009 Q4 | 1.3 Billion CNY | -3.0% |
| 2009 Q1 | 1.26 Billion CNY | 4.88% |
| 2009 Q2 | 1.36 Billion CNY | 7.52% |
| 2009 Q3 | 1.34 Billion CNY | -1.24% |
| 2009 FY | 1.3 Billion CNY | 8.02% |
| 2008 Q3 | 1.07 Billion CNY | 0.75% |
| 2008 Q4 | 1.2 Billion CNY | 12.06% |
| 2008 Q1 | 1.06 Billion CNY | 6.93% |
| 2008 FY | 1.2 Billion CNY | 20.86% |
| 2008 Q2 | 1.06 Billion CNY | 0.11% |
| 2007 Q3 | 897.31 Million CNY | 5.85% |
| 2007 Q4 | 998.75 Million CNY | 11.31% |
| 2007 FY | 998.75 Million CNY | 27.23% |
| 2007 Q1 | 845.8 Million CNY | 7.74% |
| 2007 Q2 | 847.74 Million CNY | 0.23% |
| 2006 Q4 | 785.02 Million CNY | -1.58% |
| 2006 Q2 | 881.75 Million CNY | -1.27% |
| 2006 Q1 | 893.07 Million CNY | 1.21% |
| 2006 FY | 785.02 Million CNY | -11.04% |
| 2006 Q3 | 797.63 Million CNY | -9.54% |
| 2005 Q4 | 882.44 Million CNY | -3.54% |
| 2005 Q3 | 914.8 Million CNY | 0.45% |
| 2005 Q2 | 910.71 Million CNY | -2.88% |
| 2005 Q1 | 937.73 Million CNY | 2.83% |
| 2005 FY | 882.44 Million CNY | -3.24% |
| 2004 Q2 | 911.16 Million CNY | 3.11% |
| 2004 FY | 911.95 Million CNY | 5.19% |
| 2004 Q1 | 883.67 Million CNY | 1.93% |
| 2004 Q3 | 894.26 Million CNY | -1.85% |
| 2004 Q4 | 911.95 Million CNY | 1.98% |
| 2003 Q2 | 836.92 Million CNY | 1.2% |
| 2003 Q3 | 842.24 Million CNY | 0.64% |
| 2003 Q1 | 826.98 Million CNY | 0.86% |
| 2003 FY | 866.93 Million CNY | 5.74% |
| 2003 Q4 | 866.93 Million CNY | 2.93% |
| 2002 FY | 819.9 Million CNY | 7.62% |
| 2002 Q2 | 772.19 Million CNY | 2.86% |
| 2002 Q1 | 750.71 Million CNY | -1.46% |
| 2002 Q3 | 812 Million CNY | 5.16% |
| 2002 Q4 | 819.9 Million CNY | 0.97% |
| 2001 Q2 | 731.83 Million CNY | 0.0% |
| 2001 Q4 | 761.83 Million CNY | 0.0% |
| 2001 FY | 761.83 Million CNY | 12.66% |
| 2000 Q2 | 615.2 Million CNY | 0.0% |
| 2000 FY | 676.21 Million CNY | 4.23% |
| 2000 Q4 | 676.21 Million CNY | 0.0% |
| 1999 Q4 | 648.78 Million CNY | 0.0% |
| 1999 Q2 | 401.13 Million CNY | 0.0% |
| 1999 FY | 648.78 Million CNY | 71.29% |
| 1998 FY | 378.75 Million CNY | 13.72% |
| 1997 FY | 333.04 Million CNY | 36.0% |
| 1996 FY | 244.89 Million CNY | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Zhejiang Int'l Group Co.,Ltd. | 13.9 Billion CNY | 78.219% |
| Zhejiang Zhenyuan Share Co., Ltd. | 2.98 Billion CNY | -1.519% |
| Hunan Jingfeng Pharmaceutical Co.,Ltd. | 1.06 Billion CNY | -185.71% |
| Yifan Pharmaceutical Co., Ltd. | 11.49 Billion CNY | 73.655% |
| Guangdong Jiaying Pharmaceutical Co., Ltd | 847.56 Million CNY | -257.439% |
| Sichuan Kelun Pharmaceutical Co., Ltd. | 36.52 Billion CNY | 91.706% |
| Chongqing Lummy Pharmaceutical Co., Ltd. | 2.89 Billion CNY | -4.796% |
| Boai NKY Medical Holdings Ltd. | 4.01 Billion CNY | 24.633% |
| Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. | 2.56 Billion CNY | -18.24% |